|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-5-14
|
|
pubmed:abstractText |
Calcitonin gene-related peptide (CGRP) is one of the neuroendocrine markers. The serum CGRP levels in untreated prostate cancer (PCa) patients reportedly reflect the tumor volume and aggressiveness. However, the detailed evaluation of the serum CGRP levels in the PCa patients treated with hormonal therapy (HT) has never been reported. We measured the serum CGRP levels in PCa patients receiving HT to elucidate its clinical significance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0399
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
291-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19440016-Aged,
pubmed-meshheading:19440016-Aged, 80 and over,
pubmed-meshheading:19440016-Antineoplastic Agents, Hormonal,
pubmed-meshheading:19440016-Calcitonin Gene-Related Peptide,
pubmed-meshheading:19440016-Humans,
pubmed-meshheading:19440016-Immunoradiometric Assay,
pubmed-meshheading:19440016-Male,
pubmed-meshheading:19440016-Middle Aged,
pubmed-meshheading:19440016-Neoplasm Staging,
pubmed-meshheading:19440016-Prostatic Neoplasms,
pubmed-meshheading:19440016-Treatment Outcome,
pubmed-meshheading:19440016-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Significance of serum calcitonin gene-related peptide levels in prostate cancer patients receiving hormonal therapy.
|
|
pubmed:affiliation |
Department of Urology, Jichi Medical University, Shimotsuke-City, Tochigi, Japan. s.kazu@jichi.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
